Epigenetic changes mediated by loss of function of TET methylcytosine dioxygenase 2 (TET2) have been observed in CD19-targeted CAR-T cells in patients with chronic lymphocytic leukemia. The gene discussed is TET2; the disease is B-cell chronic lymphocytic leukemia.